Brugada syndrome: Progress in genetics, risk stratification and management

Jorge E. Romero, Dan L. Li, Ricardo Avendano, Juan Carlos Diaz, Roderick Tung, Luigi Di Biase

Research output: Contribution to journalArticle

Abstract

Brugada syndrome (BrS) is one of the most common causes of sudden cardiac death in normal structural heart individuals. First characterised in 1992, the global prevalence of BrS is unclear, with estimates placing it at around 0.05% and presenting most frequently in southeast Asian countries. This review aims to summarise the development in the understanding of BrS and, importantly, progress in its management, underpinned by knowledge regarding its genetics and molecular mechanisms. It also provides update on risk stratification and promising new therapies for BrS, including epicardial ablation. Future studies are required to increase understanding of the pathogenesis of this disease and to guide clinical practice.

Original languageEnglish (US)
Pages (from-to)19-27
Number of pages9
JournalArrhythmia and Electrophysiology Review
Volume8
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Brugada Syndrome
Risk Management
Knowledge Management
Sudden Cardiac Death
Molecular Biology

Keywords

  • Brugada syndrome
  • Epicardial ablation
  • Genetic testing
  • Radiofrequency ablation
  • Risk stratification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Brugada syndrome : Progress in genetics, risk stratification and management. / Romero, Jorge E.; Li, Dan L.; Avendano, Ricardo; Diaz, Juan Carlos; Tung, Roderick; Di Biase, Luigi.

In: Arrhythmia and Electrophysiology Review, Vol. 8, No. 1, 01.03.2019, p. 19-27.

Research output: Contribution to journalArticle

Romero, Jorge E. ; Li, Dan L. ; Avendano, Ricardo ; Diaz, Juan Carlos ; Tung, Roderick ; Di Biase, Luigi. / Brugada syndrome : Progress in genetics, risk stratification and management. In: Arrhythmia and Electrophysiology Review. 2019 ; Vol. 8, No. 1. pp. 19-27.
@article{d6548e56ee5d4b57ba98615ded561b52,
title = "Brugada syndrome: Progress in genetics, risk stratification and management",
abstract = "Brugada syndrome (BrS) is one of the most common causes of sudden cardiac death in normal structural heart individuals. First characterised in 1992, the global prevalence of BrS is unclear, with estimates placing it at around 0.05{\%} and presenting most frequently in southeast Asian countries. This review aims to summarise the development in the understanding of BrS and, importantly, progress in its management, underpinned by knowledge regarding its genetics and molecular mechanisms. It also provides update on risk stratification and promising new therapies for BrS, including epicardial ablation. Future studies are required to increase understanding of the pathogenesis of this disease and to guide clinical practice.",
keywords = "Brugada syndrome, Epicardial ablation, Genetic testing, Radiofrequency ablation, Risk stratification",
author = "Romero, {Jorge E.} and Li, {Dan L.} and Ricardo Avendano and Diaz, {Juan Carlos} and Roderick Tung and {Di Biase}, Luigi",
year = "2019",
month = "3",
day = "1",
doi = "10.15420/aer.2018.66.2",
language = "English (US)",
volume = "8",
pages = "19--27",
journal = "Arrhythmia and Electrophysiology Review",
issn = "2050-3369",
publisher = "Radcliffe Publishing Ltd.",
number = "1",

}

TY - JOUR

T1 - Brugada syndrome

T2 - Progress in genetics, risk stratification and management

AU - Romero, Jorge E.

AU - Li, Dan L.

AU - Avendano, Ricardo

AU - Diaz, Juan Carlos

AU - Tung, Roderick

AU - Di Biase, Luigi

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Brugada syndrome (BrS) is one of the most common causes of sudden cardiac death in normal structural heart individuals. First characterised in 1992, the global prevalence of BrS is unclear, with estimates placing it at around 0.05% and presenting most frequently in southeast Asian countries. This review aims to summarise the development in the understanding of BrS and, importantly, progress in its management, underpinned by knowledge regarding its genetics and molecular mechanisms. It also provides update on risk stratification and promising new therapies for BrS, including epicardial ablation. Future studies are required to increase understanding of the pathogenesis of this disease and to guide clinical practice.

AB - Brugada syndrome (BrS) is one of the most common causes of sudden cardiac death in normal structural heart individuals. First characterised in 1992, the global prevalence of BrS is unclear, with estimates placing it at around 0.05% and presenting most frequently in southeast Asian countries. This review aims to summarise the development in the understanding of BrS and, importantly, progress in its management, underpinned by knowledge regarding its genetics and molecular mechanisms. It also provides update on risk stratification and promising new therapies for BrS, including epicardial ablation. Future studies are required to increase understanding of the pathogenesis of this disease and to guide clinical practice.

KW - Brugada syndrome

KW - Epicardial ablation

KW - Genetic testing

KW - Radiofrequency ablation

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=85063400494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063400494&partnerID=8YFLogxK

U2 - 10.15420/aer.2018.66.2

DO - 10.15420/aer.2018.66.2

M3 - Article

AN - SCOPUS:85063400494

VL - 8

SP - 19

EP - 27

JO - Arrhythmia and Electrophysiology Review

JF - Arrhythmia and Electrophysiology Review

SN - 2050-3369

IS - 1

ER -